Rolle der Mastzelle bei allergischem Asthma bronchiale
| 23. | Taube, C. and Maurer, M.: Role of mast cells in the development of allergic asthma. Allergo J. 2008: 17; 297-300. IF: N/A |
Results
Found 544 hits.
Search Results for: L3M2 Studienmaterialien: Ethical Procurement and Supply - L3M2 Torrent Prüfung - L3M2 wirkliche Prüfung 🍱 Suchen Sie auf （ www.itzert.com ） nach 《 L3M2 》 und erhalten Sie den kostenlosen Download mühelos 🙁L3M2 Prüfungs-Guide – Page 16
Atopic dermatitis and allergic rhinitis – do co-effects in therapy exist?
| 58. | Weller, K., Soost, S., Worm, M., Maurer, M., and Zuberbier, T.: Atopic dermatitis and allergic rhinitis – do co-effects in therapy exist? J. Dtsch. Dermatol. Ges. 2012: 10; 221-239. IF: 1.40 |
Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema
| 179 | Aberer, W.+, Maurer, M. Reshef, A., Longhurst, H., Kivity, S., Bygum, A., Caballero, T., Bloom, B., Nair, N., and Malbrán, A.: Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema. Allergy 2014: 69; 305-314. IF: 6.03 |
Antihistamines in the Treatment of Urticaria
| 54. | Zuberbier, T. and Maurer, M.: Antihistamines in the treatment of urticaria. Adv. Exp. Med. Biol. 2011: 709; 67-72. IF: 1.37 |
Antihistamines in the treatment of urticaria
| 15. | Zuberbier, T. and Maurer, M.: Antihistamines in the treatment of urticaria. In: Thurmond, R. L., editor: Histamine in inflammation. Texas: Springer Science + Business Media, LLC, Landes Bioscience, 2010 |
The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebocontrolled treatment with rupatadine 10 and 20 mg
| 78 | Giménez-Arnau, A., Izquierdo, I.+, and Maurer, M.: The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg. J. Eur. Acad. Dermatol. Venereol. 2009: 23; 1088-1091. IF: 2.79 |
o.078
Long-term reduction in local inflammation by a lipid raft molecule in atopic dermatitis
| 100 | Dölle, S., Hoser, D., Rasche, C., Loddenkemper, C., Maurer, M. Zuberbier, T., and Worm, M.+: Long-term reduction in local inflammation by a lipid raft molecule in atopic dermatitis. Allergy 2010: 65; 1158-1165. IF: 6.29 |
Analysis of disease activity categories in chronic spontaneous/idiopathic urticaria
| 284 | Stull, D.+, McBride, D., Tian, H., Giménez-Arnau, A., Maurer, M. Marsland, A., Balp, M. M., Khalil, S., and Grattan, C.: Analysis of disease activity categories in chronic spontaneous/idiopathic urticaria. Brit. J. Dermatol. 2017: 177; 1093-1101. IF: 6.13 |
The urticaria activity score – validity, reliability, and responsiveness
| 322 | Hawro, T., Ohanyan, T., Schoepke, N., Metz, M., Peveling-Oberhag, A., Staubach, P., Maurer, M. and Weller, K.+: The urticaria activity score – validity, reliability, and responsiveness. J. Allergy Clin. Immunol. Pract. 2018: 6; 1185-1190. IF: 7.55 |
Mastozytose
| 19. | Maurer, M.: Mastozytose. In: Plewig, G., Landthaler, M., Burgdorf, W., Hertl, M. and Ruzicka, T., editors: Braun-Falco’s Dermatologie, Venerologie und Allergologie. 6. Auflage, Heidelberg: Springer, 2012 |